Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Research and development expenses	$ 412	$ 391	$ 889	$ 495
Marketing expenses	130	593	181	763
General and administrative expenses	429	532	754	690
Total operating loss	971	1,516	1,824	1,948
Financial expenses (income), net	(32)	6	(36)	18
Loss for the period	$ 939	$ 1,522	$ 1,788	$ 1,966
Basic and dilutive loss per common stock (in dollars)	$ (0.01)	$ 0.02	$ (0.03)	$ (0.03)
Weighted average number of ordinary shares	68,238,013	64,601,649	66,419,831	61,619,878